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Abstract: Interest in chronic conditions reflects their role as the first cause of death and disability
in developed countries; improving the management of these conditions is a priority for health care
services. The aim of this study was to establish which sociodemographic factors influence adherence
to standards of care for chronic heart failure (CHF). A generalized multilevel structural equation
model was developed and applied to a sample of patients with CHF obtained from administrative
data flows in six Italian regions to ascertain any associations between adherence to standards of care
for CHF and sociodemographic variables. Indicators of compliance were adherence to beta-blocker
therapy (BB-A) and Angiotensin Convertin Enzime inhibitor/Angiotensin Receptor Blocker therapy
(ACE-A), and creatinine and electrolyte testing (CNK-T). All indicators were computed over a
one-year follow-up. Among a cohort of 24,997 patients, the BB-A rate was 40.4%, the ACE-A rate
61.1%, and the CNK-T rate 57.0%. Factors found associated with adherence were gender, age, and
citizenship. Our study shows an inadequate adherence to standards of care for CHF, particularly
associated with certain sociodemographic characteristics. This suggests the need to improve the role
of primary care in managing this chronic condition. The measures considered only apply to patients
with a reduced Left Ventricular Ejection Fraction, hence a limitation of this analysis is the lack of
information on left ventricular ejection.
Keywords: primary health care; health care research; quality of care; inequalities
1. Introduction
The prevalence of non-communicable diseases [1] is rising and chronic conditions have become the
leading cause of death and disability, thus coming to represent a primary concern for the health services.
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This is mainly due to the aging of the population, the survival of patients after acute events that leave
disabling sequelae, and the availability of treatments that give patients a longer life expectancy. Many
patients with chronic conditions are treated by primary care services, making good-quality chronic
care a challenge. This is particularly true when general practitioners (GPs) fail to adopt evidence-based
guidelines for managing chronic conditions, and when patients are unwilling or unable to follow their
GP’s recommendations. In other words, a strong degree of adherence is essential, and this can only be
achieved when both doctor and patient perceive that a treatment has more benefits than risks or costs.
According to the World Health Organization (WHO) [2], it is important to study the phenomenon
of adherence to drug treatment, and adherence to behavioral measures and follow-up procedures.
It is also essential to analyze the determinants of adherence in order to identify population groups
likely to be scarcely compliant with disease management programs. Adherence to appropriate chronic
disease management programs is a multifaceted issue influenced by how health care is delivered and
by patient-related factors (called antecedents) that may have an impact on an individual’s propensity to
follow medical recommendations; some sociodemographic factors are among these antecedents [3].
Several studies have shown that age, ethnicity and formal education have an important influence on
adherence to health professionals’ advice [4,5], for instance. While a number of authors focused on a
particular sociodemographic dimension as a determinant of health care disparities, few studies [6,7]
have analyzed how these variables interact in their association with adherence to a good-quality
disease management program in a more complex scenario.
Among chronic conditions, chronic heart failure (CHF) is characterized by multiple relapses, with
an expected one-year hospital readmission rate of more than 50%, and one-year mortality rates of
30% [8,9]. CHF is consequently the most common hospital discharge diagnosis of all chronic conditions,
accounting for a substantial economic burden on national healthcare systems. In this light, improving
the outpatient management of CHF has been suggested as a cornerstone for preventing frequent
hospital readmissions and the related costs [10]. We found some studies that examined differences
in adherence between different population groups [11,12], but such evidence needs to be confirmed,
especially in the context of Southern Europe where the immigration phenomenon is more recent and
less developed than in Northern Europe. The countries from which immigrants come are also different.
European Statistics [13] reveal that the number of immigrants/1000 inhabitants is lower in Italy, Spain
and Portugal compared with Northern European Countries such as the United Kingdom, Germany
or Sweden. Most immigrants in Italy in 2013 came from Romania, Albania and Morocco whereas,
for example, in Germany the majority of the immigrants are from Turkey, Poland and Italy.
The aim of this study was to measure overall adherence to standards of care for CHF, considering
a complex set of factors, including many individual sociodemographic characteristics of the patients,
variability in GPs’ attitudes, and the effects of local health authorities’ stewardship in supporting and
motivating adherence to evidence-based guidelines.
2. Methods
2.1. Context
Italy is divided into 20 regions, and each regional government is responsible for fulfilling the
objectives of a National Health Plan through Local Health Authorities (LHAs), which are organized into
health districts (HDs) providing primary health care and community services. All residents registered
with the National Health Service (be they Italians or regular immigrants) have a General Practitioner
(GP) of their choice. GPs have a gate-keeping role and decide on exemptions from co-payment for
drugs and diagnostic tests for any chronic conditions, as established by the Ministry of Health.
2.2. Data and Variables
This was a retrospective cohort study. The methods used in this study have been explained
in detail elsewhere [14]. Briefly, six Italian regions took part in the VALORE project, an initiative
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of the National Agency for Regional Health Systems, for the purpose of assessing quality of care
for chronic diseases and the organization of primary health care services [5]. For organizational
reasons, the regions participating in the VALORE project did not provide administrative data for their
whole regional population, but only for specific geographical subareas. In each region, raw data were
extracted from the local data files and sent via file transfer protocol (FTP) to a single data management
center, after anonymizing the coded personal identifier. The dataset used in our analysis was generated
automatically by processing administrative records.
To identify cases of CHF we used the following administrative records: (a) hospital discharge
records with one main and up to five secondary diagnoses coded using the International Classification
of Diseases, Ninth Revision, Clinical Modification (ICD9CM); (b) disease-specific exemptions from
co-payment for health care, coded using the ICD9CM; (c) the population registry containing
demographic details (year of birth, gender).
We only enrolled people registered with the Italian National Health System (all Italian citizens
and regular immigrants, i.e., foreigners with a regular entry visa or residence permit) and we classified
nationality as follows: Italians; immigrants from highly developed countries (HDC); and immigrants
from high-migratory-pressure countries (HMPC).
To assess adherence to process indicators we used two administrative records:
1. Drug-dispensing records coded using the Anatomical Therapeutic Chemical (ATC) codes for
drug classification (adopted by the WHO), excluding drugs administered during hospital stays.
2. Outpatient care database, which records visits to specialist physicians and diagnostic tests
(without the results).
We have measured the percentage of patients who performed each of the indicators and, using
factor analysis, we have constructed a latent variable named “adherence to process indicators of a
correct follow up”, which captures the adherence to all these indicators.
In each region, record linkage within and between data files was done deterministically using a
coded personal identifier.
The standards for CHF care were chosen from those identified and established by the relevant
scientific associations. In particular, we chose three indicators that the Heart Failure Work Group [15]
considers indicative of the quality of care for CHF in terms of improving outcomes for outpatients
with CHF, i.e., adherence to therapy with ACE inhibitors or angiotensin receptor blockers (ACE-A);
adherence to therapy with beta-blockers (BB-A); monitoring of creatinine, Na and K (CNK-T) every
six months. Adherence to therapy was estimated from the presence of at least two prescriptions during
the year of follow-up, separated by an interval of at least 180 days. The three indicators were computed
over a one-year follow-up (1 January 2009 to 31 December 2009) by linking the cohort of patients to the
administrative databases recording prescriptions for drugs and diagnostic tests.
To overcome any selection bias that might undermine the validity of our results we excluded all
patients who died or were lost to follow-up because this loss was associated, in our database, with both
exposure (age group) and outcome (adherence to the process indicator).
The Charlson Index (CI) [16] was calculated by applying Charlson’s algorithm to the hospital
discharge diagnoses recorded for a patient in the previous three years. This index has proved a valid
and reliable method for measuring comorbidities for the purpose of clinical research and, although
it was first developed and validated for hospitalized patients, it has since been adapted and validated
for primary care and community populations too.
2.3. Statistical Analysis
The data were summarized as numbers (percentages) of subjects for categorical variables.
Prevalence was estimated as the total number of existing cases divided by the number of subjects in
the sample, which corresponds to the whole resident population registered in the selected geographical
subareas and alive at the index date. A standardized automated routine was developed in Stata 9.2 to
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apply a case ascertainment algorithm developed by the Tuscany Regional Public Health Agency, based
either on diagnoses (both primary and secondary) in hospital discharge records, or on disease-specific
healthcare co-payment exemptions [14]. In Italy, exemption is granted to patients in New York Heart
Association stages III or IV. CHF recorded in hospital discharge records as a primary diagnosis implies
that this condition was the main reason for admission. Its listing as a secondary diagnosis implies that
it existed already at the time of admission or developed during the hospital stay and consequently
influenced the treatment received and/or the duration of the hospital stay; this presumably happens
mainly in cases with NYHA stages III or IV. The 95% confidence intervals (CIs) were calculated using a
binomial distribution.
The chi-square statistic was used to test the hypothesis of independence between
sociodemographic and clinical factors and adherence to standards of care.
The structure of our dataset is hierarchical: individuals at level 1 are nested in their GPs (level 2),
and the GPs are nested in the HDs (level 3). We thus consider the HD level and GP level as well as the
individual level in a generalized three-level structural equation model (M-GSEM). To create the latent
variable “adherence to evidence-based quality of care for CHF patients”, we hypothesized a statistical
model in the form of a confirmatory factor analysis (CFA) defining the connections between the
three quality-of-care indicators considered as binary variables [17]. The three variables are associated
with their latent variable and this is represented graphically by arrows pointing from the constructs
towards the indicator variable. Then an integrated generalized SEM model on three levels was
formulated for the adherence outcome, considering the associations of the exogenous variables with
the three indicators of the quality of care for CHF. Age group (reference 65- to 74-year-olds), gender
(reference male), nationality (reference Italian), time since diagnosis (dichotomized as ď3 years and
>3 years), and CI (dichotomized as high/medium vs. low comorbidity) were the exogenous variables
on the first level of the G-SEM model, each GP’s identification number was on the second level, and
each HD’s identification number on the third.
2.4. Ethical Considerations
The data analysis was performed on anonymized aggregate data with no chance of individuals
being identifiable. The study complied with the Declaration of Helsinki and with Italian Law n.
196/2003 on the protection of personal data. The recent resolution n. 85/2012 of the Italian Guarantor
for the Protection of Personal Data also confirmed the allowability of processing personal data for
medical, biomedical and epidemiological research, and that data concerning health status may be used
in aggregate form in scientific studies. Permission to use unidentifiable individual data extracted from
administrative databases for the VALORE project was granted by ULSS 16 Padova, the ASP 7 Ragusa,
the Assessorato Politiche per la Salute Emilia Romagna, and the Zona Territoriale Senigallia, which are
responsible for the use of the data concerning their respective populations. The Agenzia Regionale di
Sanità della Toscana is allowed by a regional law to use Tuscan data for research purposes. Approval
for use of encrypted and aggregate data from the HSD was also obtained from the Italian College of
General Practitioners.
3. Results
The number of individuals aged 16 or more on 1 January 2009 amounted to 1,948,622
(930,891 Men vs. 10,177,319 women; 1,710,780 Italians). Among them, 16- to 44-year-old subjects
were 42% (823,935) of the sample population, whereas +85-year-olds were the least represented age
category (4%, only = 78,019).
The algorithm identified 28,062 patients as having CHF, and 24,997 of these patients completed
the one-year follow-up period. Table 1 shows the characteristics of the sample.
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Table 1. Characteristics of the sample.
Variable Modality Absolute Frequency % Relative Frequency
Gender
Men 12,394 49.58
Women 12,603 50.42
Age
16–44 303 1.21
45–64 2765 11.06
65–74 4891 19.57
75–84 9442 37.77
85+ 7596 30.39
Nationality Italian 23,606 94.45
HMPC 1 1391 5.55
Charlson index
No comorbidity 6705 26.82
Low comorbidity 6267 25.07
High comorbidity 12,025 48.11
Time since diagnosis <3 years 10,592 42.37
>3 years 14,405 57.63
1 High-Migratory-Pressure Countries.
The population rate of adherence for BB-A was 40.4%, for ACE-A it was 61.1%, and for CNK-T it
was 57.0%.
Table 2 shows the bivariate association between adherence to quality-of-care indicators and
sociodemographic characteristics. All sociodemographic variables are significantly associated with
process indicators in the bivariate analysis, except for nationality and BB-A.
Table 2. Bivariate association (chi-squared test) between adherence to standards of care and
sociodemographic characteristics.
Variable ACE-A p BB-A p CNK-T p
Gender
Men 7927 (63.96%)
0.000
5610 (45.26%)
0.000
6985 (56.36%)
0.000
Women 7337 (58.22%) 4497 (35.68%) 7273 (57.71%)
Age
16–44 110 (36.3%)
0.000
116 (38.28%) 130 (42.90%)
0.000
45–64 1788 (64.67%) 1541 (55.73%) 1340 (48.46%)
65–74 3363 (68.76%) 2510 (51.32%) 0.000 2821 (57.68%)
75–84 6099 (64.59%) 3924 (41.56%) 5731 (60.70%)
85+ 3904 (51.4%) 2016 (26.54%) 4236 (55.77%)
Nationality Italians 14,530 (51.55%) 0.000
9640 (40.84%)
0.540
13,500 (57.19%)
0.000
HMPC 86 (43.22%) 77 (38.69%) 86 (43.22%)
Charlson index
No comorbidity 4215 (62.86%)
0.000
2494 (37.20%) 3322 (49.55%)
0.000Low Comorbidity 4038 (64.43%) 2702 (43.11%) 0.000 3576 (57.06%)
High Comorbidity 7011 (58.30%) 4911 (40.84%) 7360 (61.21%)
Time since diagnosis <3 years 6376 (60.20%) 0.016
4137 (39.06%)
0.000
5763 (54.41%)
0.000
>3 years 8888 (61.70%) 5970 (41.44%) 8495 (58.97%)
The estimated overall prevalence of CHF in the general population over 16 years old was 1.44%
(95% CI: 1.42–1.46). Figure 1 shows the prevalence of CHF for men and women, respectively, by age
group and nationality.
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Figure 1. Prevalence of CHF (mainly stage III–IV NYHA) with 95% CI. HMPC:
High-Migratory-Pressure Countries.
Table 3 shows which var ables ar associated with adherence to process indicators in a multilevel
structural equation model. The women cat gory is associated wit a lower adherence to therapy with
ACE-I/ARB and BB whereas they seem more adherent to CNK testing. Younger patients (16–44) tend
to adhere less both to therapy and testing than the reference age category (64–75). This is also true
for patients 85+. The 45–64 category is instead associated with a higher adherence to BB therapy in
respect to the reference. And also 75- to 84-year-old patients have their creatinine and electrolytes
tested more. HMPC immigrants have lower adherence to all indicators compared to Italians. Patients
with more comorbidities (high CI) are more adherent to BB therapy and CNK testing than patients
with no/low comorbidity, but less adherent to ACE-I therapy. Patients with a more recent diagnosis
are more adherent to ACE-I therapy than patients with no or low comorbidity.
Table 3. Results of the multilevel structural equation model with adherence as a latent variable;
95% confidence intervals (CI), odds ratios and p-values for adherence to process indicators.
Indicator Variable Modality OR
95% CI
95% UL 95% LL p
ACE-A
Gender (ref. Men) Women 0.86 0.82 0.91 <0.001
Age (ref. 65–74 years)
16–44 0.26 0.20 0.34 <0.001
45–64 0.81 0.73 0.90 <0.001
75–84 0.84 0.78 0.91 <0.001
85+ 0.49 0.46 0.54 <0.001
Nationality (ref. Italians) HMPC 0.47 0.35 0.63 <0.001
Charlson Index (ref. No/low comorbidity) high comorbidity 0.85 0.81 0.88 <0.001
Time since diagnosis (ref. >3 years) ď3 years 1.21 1.14 1.29 <0.001
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Table 3. Cont.
Indicator Variable Modality OR
95% CI
95% UL 95% LL p
BB-A
Gender (ref. Men) Women 0.83 0.79 0.88 <0.001
Age (ref. 65–74 years)
16–44 0.64 0.50 0.82 <0.001
45–64 1.21 1.09 1.33 <0.001
75–84 0.69 0.64 0.74 <0.001
85+ 0.36 0.33 0.39 <0.001
Nationality (ref. Italians) HMPC 0.67 0.50 0.90 0.008
Charlson Index (ref. No/low comorbidity) high comorbidity 1.08 1.04 1.12 <0.001
Time since diagnosis (ref. >3 years) ď3 years 1.04 0.97 1.10 0.270
CNK-T
Gender (ref. Men) Women 1.06 1.01 1.13 0.029
Age (ref. 65–74 years)
16–44 0.63 0.49 0.81 <0.001
45–64 0.71 0.65 0.79 <0.001
75–84 1.11 1.03 1.20 0.007
85+ 0.90 0.83 0.98 0.010
Nationality (ref Italians) HMPC 0.66 0.49 0.90 0.007
Charlson Index (ref. No/low comorbidity) high comorbidity 1.30 1.25 1.34 <0.001
Time since diagnosis (ref. >3 years) ď3 years 0.96 0.90 1.02 0.223
The parameter estimates of the multilevel structural equation model (SEM) are also outlined
in Figure 2, showing the association of each single process variable with adherence (the latent
variable of the model), and it also illustrates the associations between single process indicators and
sociodemographic characteristics.
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Beta-Blockers; CNK-T = Creatinine, Sodium and Potassium Test).
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4. Discussion
This population-based Italian study estimated the prevalence of CHF in the Italian and immigrant
population by means of an administrative database record linkage. It revealed a suboptimal
quality of CHF patient care, and disparities in their management, to the detriment of women and
HMPC migrants.
The estimated prevalence of CHF among individuals aged 16 or more refers mainly to cases in the
symptomatic stage of the disease, since the administrative data considered here concern co-payment
exemptions and hospital discharge records involving a diagnosis of CHF. A validation study found
that querying the clinical databases of Italian GPs produces similar prevalence estimates [14], which
also resemble those reported in other European population-based studies [18] using screening methods,
although the populations investigated differed in age of enrolment and the methods used to identify
cases of CHF. The latter studies suggested a prevalence of CHF in the range of 1% to 2% [19].
Our data on the Italian population showed a higher prevalence in males than in females for all
age groups (1.59% in Italian men and 1.5% in Italian women). The MONICA study [20] reported that
the prevalence of definite Left Ventricular Sistolic Disfunction (ejection fraction of 30% or less) was 4%
in men and 2% in women between 25 and 74 years of age.
Our results also indicated that immigrants from HMPC generally have a lower prevalence of CHF
than native Italians. Our data only showed a statistically significant difference for 45- to 64-year-old
males, however. To our knowledge, no estimates of the prevalence of CHF among immigrants are
available in the literature, but if we consider the broader category of heart disease, several studies have
reported that immigrants have lower mortality rates of heart disease than native populations [21],
which are findings consistent with the “healthy migrant” effect already seen for other diseases [22].
Like most other chronic conditions, the most important factor influencing the prevalence of
CHF is age: like most studies conducted in North America [23] and Europe [24], our results reveal
an exponential increase in its prevalence with age for both men and women, and for both Italians
and immigrants.
Overall, our data on adherence show a poor quality of care for all the CHF management indicators
investigated, considering the thresholds of the Quality and Outcomes Framework (QOF) indicators
in England [25] and the standards defined by the Italian Society of General Medicine (SIMG) [26].
A review found that the prevalence of ACEI/ARB use in 2001 ranged from 43% to 90% (median 71%)
among patients discharged from the hospital with a known systolic dysfunction, and from 67% to
95% (median 86%) for those monitored at specialty clinics [27]. The findings of an Austrian study [28]
on discharged patients (65% ACEI/ARB, 40% BB) are more similar to ours. The databases of the
UK General Practice Extraction Service show instead that the average percentage of adherence to
ACEI/ARB therapy or dual therapy with the addition of BB in England reaches proportions of 99% and
92%, respectively. These data only refer to patients without “exceptions” (e.g., patients or caregivers
refusing the treatment, patients canceling or failing to attend appointments, or ignoring a GP’s advice),
whereas the adherence rate for the same indicators drops to 88.31% and 77.10%, respectively, when
all patients (including exceptions) were counted. Although these data might be comparable with
ours (which include all patients), they still go to show that CHF patient management is of poorer
quality in Italy than in the UK. Our data are consistent with smaller, regional studies [29] conducted in
northeastern Italy, which reported adherence rates of 72% for ACEI/ARB therapy, and 46% for BB.
In this work, we applied a generalized three-level SEM, hypothesizing an association between
adherence and sociodemographic characteristics directly linked to four indicators of quality of care for
CHF adopted in the guidelines, including an individual patient-level factor, a GP-level factor, and a
HD-level factor, to account for variability in adherence on different levels. Sociodemographic factors
had more than one significant path, being associated with almost all quality-of-care indicators. First,
we found that women are less adherent to all indicators except creatinine and electrolyte monitoring.
One of the reasons for this could lie in the different etiology of CHF by gender: the condition develops
after an acute myocardial infarction more often in men than in women, and this acute event frightens
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patients and alarms their GPs, making both of them pay more attention to the management of the
condition. Women often develop CHF after a long history of hypertension without an acute event that
might draw their attention to the problem. This theory is confirmed by the fact that women are more
compliant than men in the case of other diseases, such as diabetes [30], when there is no substantial
gender-related difference in the natural history of the condition.
Our results also show that the clinical management of CHF generally remains suboptimal in the
oldest and youngest age groups, i.e., people who may be less able or too busy to contact primary care
services. This gives rise to a higher risk of complications, rapid disease progression, and rising costs,
despite the availability of effective treatments.
Finally, our data indicate that being an immigrant reduces the likelihood of an appropriate
adherence to therapy, the odds being 53% lower for ACEI/ARB and 33% lower for BB compared to the
native Italian patients. Other studies in the US [12] show a lower adherence to therapy for CHF among
migrant patients too. Migrants may experience language difficulties, issues concerning their cultural
beliefs, and problems with obtaining transportation and/or time off work. They experience cultural
barriers to health care despite the fact that there are no financial barriers in Italy, because chronically
ill patients are exempted from charges for routine tests and drug prescriptions. Migrants who have
arrived only recently may also be unfamiliar with how the health care system works in their new place
of residence.
The WHO stated that it is essential to reorient and strengthen health systems to enable them to
respond more effectively and equitably to the healthcare needs of people with chronic diseases (action
plan). The emphasis is placed on diseases that affect women in particular, with a view to promoting
women’s health and gender equity [31]. Our findings are alarming because an inadequate management
of heart failure and of chronic heart conditions in general leads to higher costs, complications and
worse health outcomes for patients. The Italian health system still does not focus strongly enough
on primary care as a way to improve the longitudinal, comprehensive, coordinated and integrated
management of chronic conditions, and consequently contain the acute events that raise health care
costs and impair patients’ quality of life.
Judging from our findings, action is needed to reduce disparities, probably not (or not only) by
means of strategies targeting specific disadvantaged patients, such as immigrants and the elderly,
but (also) by devising a standard approach to the management of chronic conditions, and taking a
more proactive stance on primary care. An empowerment philosophy should also include interactive
teaching strategies designed to involve patients more actively in their own health care, addressing
their cultural and social needs. Making patients more responsible for their day-to-day health care [30]
could help to reduce all kinds of disparities, also assuring more disadvantaged patients timely access
to effective services. Developing specific disease management programs, involving a figure who
becomes responsible for all aspects of the patient’s care, strengthening the relationship between
doctor and patient, and adopting a pay-for-performance system in which part of a GPs’ salary is
based on their ability to prescribe appropriately and achieve health goals (also in terms of ensuring
patients’ adherence to therapies) could be an effective organizational strategy for a better-quality
management of chronic conditions. For instance, Doran et al., [32] examined the relationship between
socio-economic inequalities and the quality of the clinical care delivered in the first three years of
the P4P scheme in England. They concluded that financial incentives have the potential to make
a substantial contribution to reducing inequalities in the delivery of clinical care related to area
deprivation. It has also been underscored that a multidisciplinary approach to managing CHF can
improve patients’ clinical management and reduces the hospitalization rate and the related costs [33].
Our study has some limitations, primarily relating to the fact that not all the relevant
socio-economic factors (such as level of formal education) were available in the database. The strength
of our study lies in the fact that it was conducted on an unrestricted and unselected population of
primary care patients, thus enabling an estimation of the prevalence of the disease of interest and
of the related primary care performance measures. On the other hand, these data might be biased
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due to an opportunistic sample of LHAs being enrolled by the regional systems. This important
methodological issue was addressed in a recent paper on the consistency of the VALORE database [14]
used in the present study vis-à-vis other sources of data, such as primary care medical records and
national surveys: in the case of CHF, the VALORE prevalence estimates were systematically higher
than GPs’ estimates in all five regions considered, the largest difference being 1.4% vs. 1.1%. Another
limitation lies in that we cannot know from our data whether the patient has a CHF with a reduced
or preserved ejection fraction. This might lead to an overestimation of non-adherence to therapy
indicators since ACE inhibitors and beta-blockers are mostly indicated for CHF with a reduction of
the ejection fraction. Our study also focused on adherence to standards of care, as assessed by means
of an administrative database, so our findings could be associated not only with the quality of care
provided by physicians, but also with patient compliance. Adherence is a multifaceted behavioral
issue, however, influenced by how health care is delivered by health care providers, as well as by
patient-related factors. It is nonetheless a physician’s duty not only to prescribe appropriate therapies,
but also to monitor patients and help them adhere to their prescriptions. Moreover, there is a difference
in validity in data about drugs or diagnostic tests. Drugs appear in this record if they have been given
to the patient by the pharmacists. We are then sure that the patient has collected his drugs, but not
if he has swallowed them. However, we have considered patients to be compliant only if they had
collected drugs at least twice during the year of observation, and it is likely that if someone buys the
drugs twice in two different occasions, it is because he has finished the previous box. Instead visits
and diagnostic tests appear in this database only if they are performed. Finally, the strength of our
statistical analysis—as compared with a classical multivariate (logistic regression) method—lies in that:
(1) we investigated the direct effects of socio-economic factors on adherence, measured as a construct
variable using a model that realistically reflected the four quality-of-care indicators considered in
the CHF management guidelines; (2) we regressed the latent variable of adherence between levels to
control for the variability in adherence. Our application of this “innovative” data management model
should encourage other researchers to use this novel methodological approach more frequently in the
analysis of complex data.
5. Conclusions
Creative solutions are needed to address the escalating health care burden of chronic diseases.
Adopting evidence-based approaches for the management of chronic conditions such as CHF can
make health care systems more coherent and efficient, and provide a way to improve quality of care
across a range of chronic health problems, as well as ensuring that primary care really is a service that
comes as close as possible to where people live and work, with a level of care that guarantees fewer
health disparities across population subgroups [3]. More action is still needed to promote a proactive,
integrated approach to chronic care capable of actively involving chronically ill patients in all seasons
of their life.
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